Back to top

View the PFP Archive

Plus 5 New Strong Buys for Today
Kevin Matras   
Profit from the Pros
By Kevin Matras
Executive Vice President
Zacks Investment Research
  

Markets Up Yesterday, Poised To Close Higher For The Month

Stocks closed mostly higher yesterday, with the Dow and the S&P gaining nearly half what they gave up on Wednesday while the Nasdaq had to settle for a little less than a quarter. But it was nice to see green.

Today is the last trading day in January. At the moment, it looks like most of the indexes are on pace to close higher for the month. While the Dow is off -0.01% MTD, the S&P is up 0.83%, the Nasdaq is up 3.48%, and the small-cap Russell 2000 is up 6.67%.

As they say, as January goes, so goes the year. If that's true, it looks like we should have another solid year. Especially for tech and small-caps!

The first estimate for Q4 GDP came out at 4.0%, just under the consensus for 4.1%. That's a far cry from Q3's record of 33.4%. But it was on par with Q4 of 2019 (4.1%) before this pandemic started. And that's not too shabby.

With more and more big cities easing restrictions and letting businesses open up, Q1 looks like it could be sharply higher.

Adding to that optimism was a report that showed the vaccine by Novavax has a nearly 90% efficacy rate in Phase 3 trials in the UK.

That means we could soon have 5 vaccines in the world. The FDA has already approved vaccines from Pfizer/BioNTech, and Moderna. The UK has approved one by Oxford/AstraZeneca (and they just recently filed for FDA approval here in the states). Johnson & Johnson's vaccine is showing promising results. And now we have hopes for Novavax.

The vaccines mark the beginning of the end of the pandemic. The Fed's Jerome Powell even said as much in Wednesday's Fed Chair Press Conference.

But getting vaccines to everyone has so far been a challenge. So the more vaccines there are, the greater coverage we'll be able to see.

Soon the economy and the world will be back to normal.

And stocks are expected to soar as pent-up demand is unleashed. We saw that last year when we first came off of lockdown. That was reflected in Q3's outsized GDP. But large parts of our economy were still closed.

When it's all reopened, it's going to be amazing.

In the meantime, it's still earnings season. We've got 103 stocks on deck for today. Another 791 next week. And another 833 the week after that.

Earnings season is always an exciting time since stocks usually go up during earnings season.

So make sure you're taking full advantage of it.

Best,

Kevin Matras

Executive Vice President, Zacks Investment Research

Sponsor

5 Stocks Set to Double: Sunday Deadline

There's still time to get in on our 5 Stocks Set to Double. Each is the single favorite of a Zacks expert with the best chance to gain +100% and more in the months ahead:

1. A tech developer fueled by a record quarter in Q3 2020 with shares that have gained +113% since March 2020.
2. A multinational company that controls 80% of e-comm's market share with 15 out of 15 analysts calling this a buy today.
3. A diversified construction company poised to benefit significantly from the clean energy plan to be initiated by the new presidential administration.
4. An emerging biopharmaceutical company with a revolutionary treatment for Alzheimer's and Rett syndrome.
5. A national retailer whose in-store sales have increased 23.2% year-over-year. E-comm sales recorded an impressive 95% increase.

Deadline to download this just-released Special Report is midnight Sunday, January 31.

See Stocks Now >>

Most Popular Articles from Zacks.com

Image: Bigstock

3 Growth Tech Stocks to Buy Now After MSFT, AAPL Beat Earnings

Despite talk and some shifts out of tech into other sectors and cyclicals, technology appears poised to drive the market. Read More »

Image: Bigstock

Business Activity Perks Up in January: 5 Stocks to Buy

The services sector is poised to grow as more people regain confidence and businesses reopen. Read More »

Image: Shutterstock

3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis

The industry has outperformed both the Zacks S&P 500 composite and the broader sector over the past year gaining 33.8%. Read More »

Image: Bigstock

Biden's Big EV Pledge Puts Spotlight on These Automakers

Automakers have been going the extra mile to change gears to electric and come up with various new EV offerings. Read More »

Image: Bigstock

Investors Brace for Big Oil Q4 Earnings: What to Expect?

Despite vaccine progress and a rebound in macro conditions, commodity prices and demand are yet to reach the year-ago levels. Read More »

Sponsor

Increase Investment Returns with Free Zacks' Portfolio Tracker

Catch breaking news on your stocks and funds at a glance, including timely recommendation changes ... Zacks Ranks ... Industry Ranks ... earnings announcements ... earnings estimate revisions ... and more. And now you can screen for new stocks to improve portfolio performance.

Click for Free Tracker & Screener >>

Image: Bigstock

Bull of the Day: Goldman Sachs (GS)

The stock's $275 per share represents a robust price for a long-term investment in the gold-standard of high finance. Read More »

New Zacks Strong Buys for January 29th

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today. Read More »

 

Download our app for convenient on-the-go access to even more—daily and weekly newsletters published by Zacks experts, proprietary research and tools, and Portfolio Tracker on Zacks.com.

Download our Zacks App for Apple iOS
Download our Zacks App for Android

Visit Success Stories to hear how Zacks research, tools and portfolios help our members outperform the market.